Connection
Sabrina Spencer to Cyclin-Dependent Kinase 4
This is a "connection" page, showing publications Sabrina Spencer has written about Cyclin-Dependent Kinase 4.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.442 |
|
|
|
-
Sine CC, Watts LP, Fernandez B, Marikar N, Wang J, Knudsen ES, Witkiewicz AK, Spencer SL. p16 expression confers sensitivity to CDK2 inhibitors in cyclin E1-driven ovarian cancers. Sci Signal. 2025 Nov 25; 18(914):eadv0415.
Score: 0.234
-
Watts LP, Spencer SL. A Highly Anticipated Selective Therapeutic Agent against CDK2: INX-315. Cancer Discov. 2024 Mar 01; 14(3):386-388.
Score: 0.208